dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Gomez-Puerto, Diego |
dc.contributor.author | Llop Guevara, Alba |
dc.contributor.author | Cruellas Lapeña, Mara |
dc.contributor.author | Torres Esquius, Sara |
dc.contributor.author | De la Torre Fdez de Vega, Fco Javier |
dc.contributor.author | Peg Camara, Vicente |
dc.contributor.author | Balmaña Gelpí, Judith |
dc.contributor.author | Pimentel, Isabel |
dc.date.accessioned | 2022-10-26T10:33:33Z |
dc.date.available | 2022-10-26T10:33:33Z |
dc.date.issued | 2022-09-14 |
dc.identifier.citation | Gomez-Puerto D, Llop-Guevara A, Cruellas M, Torres-Esquius S, De La Torre J, Peg V, et al. Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report. Front Oncol. 2022 Sep 14;12:963728. |
dc.identifier.issn | 2234-943X |
dc.identifier.uri | https://hdl.handle.net/11351/8348 |
dc.description | Biomarcadors HRD; Resposta patològica completa; Càncer de mama triple negatiu |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Oncology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Tractament |
dc.subject | ADN - Reparació |
dc.subject | Quimioteràpia combinada |
dc.subject.mesh | Triple Negative Breast Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Neoadjuvant Therapy |
dc.subject.mesh | DNA Repair |
dc.title | Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fonc.2022.963728 |
dc.subject.decs | neoplasias de mama triple negativos |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | tratamiento neoadyuvante |
dc.subject.decs | reparación del ADN |
dc.relation.publishversion | https://doi.org/10.3389/fonc.2022.963728 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Gomez-Puerto D] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Llop-Guevara A] Experimental Therapeutics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Barcelona Hospital Universitari, Barcelona, Spain. [Cruellas M, Torres-Esquius S, Balmaña J] Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [De La Torre J] Unitat de Ginecologia Oncològica i Patologia Mamària, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Peg V] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pimentel I] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Breast Cancer and Melanoma Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 36185283 |
dc.identifier.wos | 000861846300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |